Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: Final results

Journal of Thoracic Oncology

Volumn 3, Issue 2, 2008, Pages 152-157

  Gottfried, Maya ^a   Ramlau, Rodryg ^b   Krzakowski, Maciej ^c   Ziolo, Grzegorz ^d   Olechnowicz, Henryk ^e   Koubkova, Leona ^f   Dahabreh, Jubrail ^g   Szczesna, Aleksandra ^h   Vivanco, Guillermo Lopez ⁱ   Perng, Reury Perng ^j   Carpagnano, Francesco ^k   Leong, Swan Swan ^l   Fittipaldo, Alberto ^m   De Almeida, Cecilia ^a,m   Aubert, Delphine ^m   Grunenwald, Dominique ⁿ  

^a MEIR MEDICAL CENTER   (Israel)

^b Oncology Department   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

^d Specjalistyczny Szpital IM   (Poland)

^e Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^f Athens Medical Centre ^*

^g ATHENS MEDICAL CENTER   (Greece)

^h III Oddzial Chorob Pluc   (Poland)

ⁱ HOSPITAL DE CRUCES   (Spain)

^j TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^k Presidio Ospedaliero San Paolo   (Italy)

^l National Cancer Center   (Singapore)

^m INSTITUT DE RECHERCHE PIERRE FABRE   (France)

ⁿ HÔPITAL TENON   (France)

more..

Author keywords

Adjuvant chemotherapy; Downstaging; Neo adjuvant chemotherapy; Nonsmall cell lung cancer; Stage III; Triplet combination

Indexed keywords

CISPLATIN; CISPLATIN DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; ASTHENIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG TOLERANCE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INFECTION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PAIN; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 40049089907     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318160c0e7     Document Type: Article

References (13)

1. N Martini MG Kris BJ Flehinger Preoperative chemotherapy for stage IIIA(N2) lung cancer: the Soloan Kettering experience with 136 patients Ann Thorac Surg 55 1993 1365 1374
2. MR Johnson Selecting patients with lung cancer for surgical therapy Semin Oncol 15 1988 246 254
3. R Rosell J Gomez-Codina C Camps A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer N Engl J Med 330 1994 153 158
4. A Depierre B Milleron D Moro-Sibilot Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), EE, and IIIa non-small-cell-lung-cancer J Clin Oncol 20 2002 247 253
5. E Baldini C Tibaldi Chella Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer Ann Oncol 7 1996 747 749
6. PJ Souquet P Fournel CH Bohas Cisplatin and ifosfamide with various doses of vinorelbine (Navelbine®) in advanced non-small cell lung cancer Semin Oncol 23 Suppl 2 1996 8 10
7. EH Tan PT Ang KS Wee Navelbine (NVB), ifosfamide (Ifo) and cisplatin (CDDP) in advanced non-small cell lung cancer (Abstract) Lung Cancer 47 Suppl 1 1997 177
8. M Gottfried A Yelin Y Shappira Navelbine (NVB), ifosfamide (IFO) and cisplatin (CDDP) combination in the management of locally advanced non-small cell lung cancer (Abstract) Lung Cancer 29 Suppl 1 1997 101
9. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials BMJ 311 1995 899 909
10. American Joint Committee on Cancer AJCC Cancer Staging Manual 6th Ed. 2002 Springer
11. F Andre D Grunenwald J Pignon Survival of patients with resected N2 non-small cell lung cancer: evidence for a subclassification and implications J Clin Oncol 16 2000 2981 2989
12. JP van Meerbeck G Kramer van Schillte A randomised trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pets) with stage IIIA-N2 non-small-cell-lung-cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941) (Abstract) J Clin Oncol 23 2005 7015
13. M Taron R Rosell E Felip BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer Hum Mol Genet 13 2004 2443 2449